270 related articles for article (PubMed ID: 33834850)
1. Association Between Depression and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy.
Hu HL; Chen H; Zhu CY; Yue X; Wang HW; Qian G; Zhai CL; He CJ
J Am Heart Assoc; 2021 Apr; 10(8):e019071. PubMed ID: 33834850
[TBL] [Abstract][Full Text] [Related]
2. Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy.
He CJ; Zhai CL; Huang SD; Fan HY; Qian YZ; Zhu CY; Hu HL
Front Cardiovasc Med; 2022; 9():890506. PubMed ID: 35665258
[TBL] [Abstract][Full Text] [Related]
3. Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy.
He CJ; Zhu CY; Fan HY; Qian YZ; Zhai CL; Hu HL
Clin Cardiol; 2023 Dec; 46(12):1569-1577. PubMed ID: 37711064
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.
Weissler-Snir A; Allan K; Cunningham K; Connelly KA; Lee DS; Spears DA; Rakowski H; Dorian P
Circulation; 2019 Nov; 140(21):1706-1716. PubMed ID: 31630535
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy.
Wu G; Liu J; Wang S; Yu S; Zhang C; Wang D; Zhang M; Yang Y; Kang L; Zhao S; Hui R; Zou Y; Wang J; Song L
Heart; 2021 Oct; 107(19):1576-1583. PubMed ID: 33361398
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
[TBL] [Abstract][Full Text] [Related]
7. Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.
Songsirisuk N; Kittipibul V; Methachittiphan N; Charoenattasil V; Zungsontiporn N; Spanuchart I; Buppajarntham S; Mankongpaisarnrung C; Satitthummanid S; Srimahachota S; Chattranukulchai P; Boonyaratavej Songmuang S; Puwanant S
BMC Cardiovasc Disord; 2019 Jan; 19(1):1. PubMed ID: 30606129
[TBL] [Abstract][Full Text] [Related]
8. Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
Abdelfattah OM; Martinez M; Sayed A; ElRefaei M; Abushouk AI; Hassan A; Masri A; Winters SL; Kapadia SR; Maron BJ; Rowin E; Maron MS
JACC Clin Electrophysiol; 2022 Nov; 8(11):1417-1427. PubMed ID: 36424010
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of mitral L-wave in patients with hypertrophic cardiomyopathy without risk factors for sudden cardiac death.
Sugiura Y; Morimoto R; Aoki S; Yamaguchi S; Haga T; Kuwayama T; Yokoi T; Hiraiwa H; Kondo T; Watanabe N; Kano N; Fukaya K; Sawamura A; Okumura T; Murohara T
Heart Vessels; 2019 Dec; 34(12):2002-2010. PubMed ID: 31152200
[TBL] [Abstract][Full Text] [Related]
11. The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
Conway J; Min S; Villa C; Weintraub RG; Nakano S; Godown J; Tatangelo M; Armstrong K; Richmond M; Kaufman B; Lal AK; Balaji S; Power A; Baez Hernandez N; Gardin L; Kantor PF; Parent JJ; Aziz PF; Jefferies JL; Dragulescu A; Jeewa A; Benson L; Russell MW; Whitehill R; Rossano J; Howard T; Mital S
Circulation; 2023 Feb; 147(9):718-727. PubMed ID: 36335467
[TBL] [Abstract][Full Text] [Related]
12. Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy.
Liu J; Wu G; Zhang C; Ruan J; Wang D; Zhang M; Wang L; Yang Y; Li X; Wang Y; Hui R; Zou Y; Kang L; Wang J; Song L
Heart Rhythm; 2020 Oct; 17(10):1658-1663. PubMed ID: 32311532
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
Bonaventura J; Rowin EJ; Chan RH; Chin MT; Puchnerova V; Polakova E; Macek M; Votypka P; Batorsky R; Perera G; Koethe B; Veselka J; Maron BJ; Maron MS
J Am Heart Assoc; 2024 May; 13(10):e033565. PubMed ID: 38757491
[TBL] [Abstract][Full Text] [Related]
14. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
[TBL] [Abstract][Full Text] [Related]
15. Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians.
Choi YJ; Kim HK; Lee SC; Park JB; Moon I; Park J; Kim YJ; Sohn DW; Ommen S
Heart; 2019 Dec; 105(24):1892-1897. PubMed ID: 31383719
[TBL] [Abstract][Full Text] [Related]
16. Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy.
Kang KW; Janardhan AH; Jung KT; Lee HS; Lee MH; Hwang HJ
Heart Rhythm; 2014 Aug; 11(8):1433-40. PubMed ID: 24813377
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Implication of First-Degree Atrioventricular Block in Patients With Hypertrophic Cardiomyopathy.
Higuchi S; Minami Y; Shoda M; Shirotani S; Saito C; Haruki S; Gotou M; Yagishita D; Ejima K; Hagiwara N
J Am Heart Assoc; 2020 Mar; 9(6):e015064. PubMed ID: 32146896
[TBL] [Abstract][Full Text] [Related]
18. Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids).
Norrish G; Ding T; Field E; Ziólkowska L; Olivotto I; Limongelli G; Anastasakis A; Weintraub R; Biagini E; Ragni L; Prendiville T; Duignan S; McLeod K; Ilina M; Fernández A; Bökenkamp R; Baban A; Kubuš P; Daubeney PEF; Sarquella-Brugada G; Cesar S; Marrone C; Bhole V; Medrano C; Uzun O; Brown E; Gran F; Castro FJ; Stuart G; Vignati G; Barriales-Villa R; Guereta LG; Adwani S; Linter K; Bharucha T; Garcia-Pavia P; Rasmussen TB; Calcagnino MM; Jones CB; De Wilde H; Toru-Kubo J; Felice T; Mogensen J; Mathur S; Reinhardt Z; O'Mahony C; Elliott PM; Omar RZ; Kaski JP
JAMA Cardiol; 2019 Sep; 4(9):918-927. PubMed ID: 31411652
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
Chan RH; Maron BJ; Olivotto I; Pencina MJ; Assenza GE; Haas T; Lesser JR; Gruner C; Crean AM; Rakowski H; Udelson JE; Rowin E; Lombardi M; Cecchi F; Tomberli B; Spirito P; Formisano F; Biagini E; Rapezzi C; De Cecco CN; Autore C; Cook EF; Hong SN; Gibson CM; Manning WJ; Appelbaum E; Maron MS
Circulation; 2014 Aug; 130(6):484-95. PubMed ID: 25092278
[TBL] [Abstract][Full Text] [Related]
20. QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy.
Patel SI; Ackerman MJ; Shamoun FE; Geske JB; Ommen SR; Love WT; Cha SS; Bos JM; Lester SJ
Acta Cardiol; 2019 Feb; 74(1):53-58. PubMed ID: 29513133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
